Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04202393 · ClinicalTrials.gov registry record · NA

Intervention for Comorbid Substance Use and Bipolar Disorders

A NA study, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
178
Enrollment target

NCT04202393: Completed NA study, sponsored by Butler Hospital.

NCT04202393 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 178 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04202393, a NA study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target

Study Summary

This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive an enhanced safety monitoring program, both provided in addition to their routine care.

Primary Outcome

The Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C) assesses depressive symptom severity. Total scores range from 0 to 27 and higher scores indicated higher symptom severity.

Interventions

  • BEHAVIORAL Integrated Treatment Adherence Program (ITAP)
  • BEHAVIORAL Safety Assessment and Follow-up Evaluation (SAFE)

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2020-10-21
Est. Completion 2025-08-31
Phase NA
Butler Hospital

103 total trials

What the finished NCT04202393 record still lists

NCT04202393 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 2 interventions - of which Integrated Treatment Adherence Program (ITAP) is the first listed.

NCT04202393 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04202393 about?

NCT04202393 is a clinical study titled "Intervention for Comorbid Substance Use and Bipolar Disorders". This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive a...

What is the current status of trial NCT04202393?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2020-10-21. Estimated completion is 2025-08-31.

What interventions are being tested in trial NCT04202393?

The interventions under investigation include: Integrated Treatment Adherence Program (ITAP) (BEHAVIORAL), Safety Assessment and Follow-up Evaluation (SAFE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04202393?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04202393's enrollment target sits among peer trials

178 604th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04202393, the US trial registry maintained by the National Library of Medicine. NCT04202393 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.